Micro­graphia Bio

If it were possible to watch drugs molecules at work under a microscope — seeing precisely how they act on different proteins inside cells — it would revo­lu­tionize drug development. Micro­graphia is doing just that. The company uses machine learning to analyze microscopy images at high throughput, allowing researchers and drug developers to unravel disease mechanisms at the subcellular level.